González-Moreno J, Juárez-López JS, Rodríguez-Sánchez JL

Language: Spanish
References: 32
Page: 269-275
PDF size: 598.17 Kb.

ABSTRACT

Obesity is a multifactorial etiology disease with a chronic course in which is involved genetical aspects, environmental and life style leading to a metabolical disorder. The ideal diagnosis of obesity is the measurement of real body fat. However, the body mass index (BMI) turns out advantageous for this goal in the context of health and has international acknowledgement even with its limitations.
The prevalence of obesity during pregnancy ranges from 11% to 22%, this is important if we consider that it increases the risk of multiple medical complications such as preeclampsia and gestational diabetes mellitus, among others. On the fetus, increases the risk of fetal deformations, as well as fetal programming on the adult life. The recommendation for the obese pregnant are of many levels: healthy diet with adequate weight gain, intervention on the life style (exercise, stress control), adequate intake of folic acid, among other things. The obesity on the pregnant woman creates a significant risk for the next generations with metabolic compromise clear before birth.

REFERENCES

1. Reaven G. Metabolic syndrome: Pathophysiology and implications for management of cardiovascular disease. Circulation 2002; 106: 286-288.

2. Norma Oficial Mexicana NOM-008-SSA3-2010, Para el tratamiento integral del sobrepeso y la obesidad.

3. Shah NR. Measuring adiposity in patients: the utility of body mass index percent body fat and leptin. Plos One 2012; 7: 1-7.

4. World Health Organization. Obesity: Preventing and Managing the Global Epidemic, Report of a WHO Consultation Obesity. 2000.

5. ENSANUT 2012. Encuesta Nacional de Salud y Nutrición 2012. Resultados nacionales. Primera edición. 2012.

6. Heslehurst N, Ellis LJ, Simpson H. Trends in maternal obesity incidence, rates, demographic predictors, and health inequalities in 36,821 women over a 15 years period. Br J Obstet Gynecol 2007; 114: 187-194.

7. Cabero L. Obstetricia y Medicina Materno fetal. 1ra Edición. Barcelona Espańa: Editorial Panamericana. p. 891-896.

8. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? Br Med J 2002; 325: 157-160-

9. Ehrenberg HM, Huston-Presley L, Catalano PM. The influence of obesity and gestational diabetes Mellitus on secretion and the distribution of adipose tissue in pregnancy. Am J Obstet Gynecol 2003; 189: 944-948.

10. Kinoshita T, Itoh M. Longitudinal variance of fat mass deposition during pregnancy evaluated by ultrasonography: The ratio of visceral fat to subcutaneous fat in the abdomen. Gynecol Obstet Invest 2006; 61: 115-118.

11. Deneson FC, Roberts KA, Barr SM. Obesity, pregnancy, inflammation, and vascular function. Reproduction 2010; 140: 373-385.

12. Radaelli T, Varastehpour A, Catalano PM. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 2003; 52: 2951-2158.

13. Wunatilake RP, Perlow JH. Obesity and pregnancy: clinical management of the obese gravida. Am J Obstet Gynecol 2011; 160: 106-119.

14. Huda SS, Brodie LE, Sattar N. Obesity in pregnancy: prevalence and metabolic consequences. Seminars Fetal Neonat Med 2010; 15: 70-76.

15. Catalano PM, Nizielsky SE, Shaoe J. Down regulated IRS-1 and PPAR gamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab 2002; 282: 522-533.

16. American College of Obstetricians and Gynecologists. Obesity in pregnancy. Committee Opinion No. 549. Obstet Gynecol 2013; 121: 213–7.

17. Mazaki-Tovi S, Romero R, Vaisbuch E. Maternal serum adiponectin multimers in preeclampsia. J Perinat Med 2009; 37: 349-363.

18. Kaaja R, Laivuori H, Laakso M. Evidence of a state of increased insulin resistence in preeclampsia. Metabolism 1999; 48: 892-896.

19. Catalano PM, Ehrenberg HM. The short and long term implications of maternal obesity on the mother and her offspring. Br J Obstet Gynecol 2006; 113: 1126-1133.

20. Torloni MR, Betran AP, Horta BI. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev 2009; 10: 194-203.

21. Martin AM, Berger H, Nisenbaum R. Abdominal visceral adiposity in the first trimester predicts glucose intolerance in later pregnancy. Diabetes Care 2009; 32: 1308-1310.

22. Mahmood TA. Obesity and pregnancy: an obstetrician´s view. Br J Diabetes Vasc Dis 2009; 9: 19-22.

23. Barker DJ. The fetal and infant origins of adult disease. Br Med J. 1990; 301: 1111.

24. Hanson M, Godfrey KM, Lillycrop KA. Developmental plasticity and developmental origins of non-communicable disease: the orical considerations and epigenetic mechanisms. Prog Biophys Mol Biol 2011; 106: 272-280.

25. Gluckman PD, Hanson MA, Low FM. The rol of developmental plasticity and epigenetics in human health. Birth Defects Res C Embryo Today 2011; 93: 12-18.

26. Barker DJ. In utero programming of cardiovascular disease. Theriogenology 2000; 53: 555-574.

27. Dabelea D, Hanson RL, Lindsay RS, et al. Intauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 2000; 49: 2208-2211.

28. Gluckman PD, Hanson MA, Cooper C, et al. Effect of in utero and early-life conditions on adult health and disease New Engl J Med 2008; 359: 61-73.

29. Huang RC, Burke V, Newnham JP, et al. Perinatal and childhood origins of cardiovascular disease. Int J Obes 2007; 31: 236-244.

30. Ramachandran P. Maternal nutrition effect on fetal growth and outcome of pregnancy. Nutr Rev 2002; 60: S26-34.

31. Ogunyemi D. Pregnancy body mass index, weight gain during pregnancy and perinatal outcome in a rural black population. J Matern Fetal Med 1998; 7: 190-193.

32. ACOG Committe on obstetric practice. Obesity in Pregnancy. Obstet Gynecol 2005; 106: 671-675.